Evidence-based articles, treatment guides, and the latest news in addiction recovery and mental health.
Senate Bill 249 decriminalizes drug paraphernalia possession and expands sterile supply distribution, sparking disagreement over public safety and addiction treatment approaches.
UC San Francisco and Imperial College London researchers discover that one 25mg dose of psilocybin creates measurable anatomical brain changes lasting at least a month.
Michigan Attorney General Dana Nessel unveils comprehensive spending guidance and public reporting tools to ensure opioid settlement funds reach communities in need.
Despite rapid expansion of telehealth mental health services, a major JAMA study reveals only modest gains in reaching rural and underserved patients.
State auditor finds Arizona Department of Corrections may have unlawfully spent opioid settlement money without proving inmates contracted hepatitis C from IV drug use.
CDC reports nearly 70,000 overdose deaths in 2025, a 14% drop and the longest sustained decline in decades, though challenges remain in several states.
As overdose deaths finally begin to fall, a new class of ultra-potent synthetic opioids is emerging in the US drug supply, presenting unprecedented challenges for detection and treatment.
A legal battle over Philadelphia's plan to use opioid settlement funds for neighborhood revitalization raises fundamental questions about how communities should spend billions in recovery dollars.
Achieve Life Sciences assembles veteran pharmaceutical leadership team from Verona Pharma ahead of FDA decision on cytisinicline, the first novel smoking cessation therapy since 2006.